{"id":"W2749878693","doi":"10.1200/jco.2017.35.15_suppl.4003","title":"KEYNOTE-059 cohort 1: Efficacy and safety of pembrolizumab (pembro) monotherapy in patients with previously treated advanced gastric cancer.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":173,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Tolerability; Cohort; Internal medicine; Cancer; Discontinuation; Oncology; Gastroenterology; Surgery; Adverse effect; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001568844,0.0007377997,0.0008206493,0.0003475662,0.0004994003,0.0006457289,0.0006976657,0.0005406477,0.00499841],"category_scores_gemma":[0.001538236,0.0003112828,0.0009841631,0.0003967354,0.000295001,0.0005774444,0.0006287663,0.000986028,0.0009657748],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001277838,"about_ca_system_score_gemma":0.001784229,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001976317,"about_ca_topic_score_gemma":0.004384035,"domain_scores_codex":[0.9995279,0.0001312567,0.00004495764,0.0001330864,0.00009326214,0.00006950359],"domain_scores_gemma":[0.9988688,0.0001200495,0.0003963448,0.0001743319,0.0001411674,0.0002991767],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3897817,0.01961638,0.4226466,0.001254935,0.005044225,0.00111784,0.0005420467,0.001769197,0.02940722,0.000329471,0.02749719,0.1009932],"study_design_scores_gemma":[0.1420597,0.1510924,0.6576744,0.0002430634,0.003830255,0.003342522,0.0003024475,0.001772535,0.01018249,0.000317054,0.02906375,0.0001192686],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9810171,0.001687941,0.00036034,0.0002379357,0.00006491464,0.001043033,0.01380166,0.000038598,0.001748562],"genre_scores_gemma":[0.9708401,0.000737039,0.0007043914,0.0005194097,0.0001360988,0.0007135616,0.02467623,0.00001699326,0.001656171],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00499841,"threshold_uncertainty_score":0.01672137,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04503207699257356,"score_gpt":0.4131629942430535,"score_spread":0.36813091725048,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}